Structure Therapeutics, Inc. (GPCR)
21.94
+0.46
(+2.14%)
USD |
NASDAQ |
Oct 29, 16:00
21.96
+0.02
(+0.07%)
After-Hours: 20:00
Structure Therapeutics Market Cap : 1.563B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.563B |
| October 28, 2026 | 1.530B |
| October 27, 2026 | 1.535B |
| October 26, 2026 | 1.503B |
| October 23, 2026 | 1.509B |
| October 22, 2026 | 1.562B |
| October 21, 2026 | 1.568B |
| October 20, 2026 | 1.629B |
| October 19, 2026 | 1.568B |
| October 16, 2026 | 1.501B |
| October 15, 2026 | 1.580B |
| October 14, 2026 | 1.558B |
| October 13, 2026 | 1.589B |
| October 12, 2026 | 1.703B |
| October 09, 2026 | 1.819B |
| October 08, 2026 | 1.828B |
| October 07, 2026 | 1.900B |
| October 06, 2026 | 1.956B |
| October 05, 2026 | 1.965B |
| October 02, 2026 | 1.971B |
| October 01, 2026 | 2.064B |
| September 30, 2026 | 2.227B |
| September 29, 2026 | 2.328B |
| September 28, 2026 | 2.497B |
| September 25, 2026 | 2.559B |
| Date | Value |
|---|---|
| September 24, 2026 | 2.565B |
| September 23, 2026 | 2.560B |
| September 22, 2026 | 2.629B |
| September 21, 2026 | 2.622B |
| September 18, 2026 | 2.493B |
| September 17, 2026 | 2.500B |
| September 16, 2026 | 2.528B |
| September 15, 2026 | 2.774B |
| September 14, 2026 | 2.738B |
| September 11, 2026 | 2.753B |
| September 10, 2026 | 2.817B |
| September 09, 2026 | 2.936B |
| September 08, 2026 | 2.876B |
| September 04, 2026 | 3.371B |
| September 03, 2026 | 3.371B |
| September 02, 2026 | 3.404B |
| September 01, 2026 | 3.357B |
| August 31, 2026 | 3.270B |
| August 28, 2026 | 3.374B |
| August 27, 2026 | 3.505B |
| August 26, 2026 | 3.515B |
| August 25, 2026 | 3.555B |
| August 24, 2026 | 3.490B |
| August 21, 2026 | 3.496B |
| August 20, 2026 | 3.598B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.293T |
| Novo Nordisk A/S | 130.96B |
| Pfizer Inc. | 170.69B |
| Viking Therapeutics, Inc. | 3.425B |
| Liquidia Corp. | 4.009B |
Market Cap Related Metrics
| Price to Book Value | 1.154 |
| Price | 21.94 |
| Earnings Yield | -14.04% |